Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 297

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 297
---
 Net cash provided by investing activities |     |            |         — |   |     |            |     58,621 |   |
| Net cash provided by financing activities |     |            | 2,699,200 |   |     |            |          — |   |
| Net decrease in cash and restricted cash  |     | $          | 1,882,656 |   |     | $          | (1,222,266 | ) |

For the six months ended June 30, 2025 and 2024 Operating activities Net cash used in operating activities amounted to $0.8 million and $1.3 million for the six months ended June 30, 2025 and 2024, respectively. The net cash used in operating activities declined due to the implementation of stringent budgetary control measures, as a result of the Company’s exclusive emphasis on the previously anticipated Merger.

159

Investing activities Net cash provided by investing activities amounted to nil and $0.1 million for the six months ended June 30, 2025 and 2024, respectively. The decrease in net cash provided by investing activities was due to the decrease in proceed from disposal of fixed assets. Financing activities Net cash provided by financing activities amounted to 2.7milliom and nil for the six months ended June 30, 2025 and 2024, respectively. The increase in net cash inflow from financing activities is attributed to the placing of shares during the period. Statement Regarding Unaudited Financial Information The unaudited financial information set forth above is subject to adjustments that may be identified when audit work is performed on the Company’s year -endfinancial statements, which could result in significant differences from this unaudited financial information. Results of Operations for the Years ended December 31, 2024, and 2023 During the second quarter of 2023, the Company decided to streamline its operations by terminating clinic services and suspending non -leadR&D projects. This measure is aimed at optimizing the allocation of our resources and focusing our efforts on advancing our lead projects, which hold the most promise for commercial success and beneficial impact. This decision aligns with our commitment to enhance shareholder value and effectively drive our core objectives forward in the competitive landscape. The following table summarizes our results of operations for the years ended December 31, 2024, and 2023.

|                                                                          |     | Year Ended   
 December 31, 
 2024         |            |   |